NCT00049140View on ClinicalTrials.gov

EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

October 31, 2004

Conditions
Head and Neck Cancer
Interventions
DRUG

EF5

OTHER

bioluminescence

OTHER

flow cytometry

OTHER

immunohistochemistry staining method

PROCEDURE

biopsy

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

David M. Brizel, MD

OTHER

NCT00049140 - EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer | Biotech Hunter | Biotech Hunter